INFLAMMOPHARMACOLOGY is a premier journal published by SPRINGER BASEL AG, specializing in the evolving fields of immunology and pharmacology. Established in 1991, the journal has made significant strides in contributing to the understanding of inflammation-related disorders, therapeutic innovations, and the pharmacological implications associated with these conditions. With an impressive Q2 ranking in Immunology and Q1 rankings in both Pharmacology and Medical Pharmacology for 2023, alongside notable Scopus rankings, INFLAMMOPHARMACOLOGY maintains its position at the forefront of scientific research. The journal provides a vital platform for researchers and practitioners to disseminate groundbreaking findings and explore novel approaches in therapeutics, reinforcing the importance of evidence-based medicine. Accessible exclusively through traditional subscription options, it continues to attract a diverse readership invested in advancing knowledge within these cutting-edge disciplines.

TURKISH JOURNAL OF BIOLOGY, published by the Tubitak Scientific & Technological Research Council Turkey, is an esteemed peer-reviewed periodical that serves as a pivotal platform for advancing the fields of Agricultural and Biological Sciences. With a strong focus on innovative research across various biological domains, including Cell Biology, Genetics, and Microbiology, this journal not only fulfills the academic community's quest for high-quality research but also fosters collaboration and knowledge sharing among researchers. The journal's notable impact factors reflect its commitment to excellence, with its latest rankings placing it in Q2 in Agricultural and Biological Sciences (miscellaneous) and in Q4 for several other categories. By offering open access to its content, TURKISH JOURNAL OF BIOLOGY ensures that valuable biological insights are readily available to the global academic community. Its convergence from 2006 to 2024 signifies its longstanding influence in the biosciences, making it an essential resource for researchers, professionals, and students alike aiming to stay at the forefront of biological research and innovation.

MEDICINE, published by Lippincott Williams & Wilkins, is an esteemed open access journal in the field of general medicine, holding a significant position with a Scopus rank of #190 out of 636 in its category (2023), placing it in the 70th percentile. Since its inception in 1922, MEDICINE has been a vital platform for researchers, professionals, and students to disseminate groundbreaking findings and advancements in the medical field. With the transition to open access in 2014, the journal ensures that valuable research is readily available to a global audience, fostering collaboration and innovation across diverse medical disciplines. Its current impact factor and influence in the miscellaneous medicine category (Q3) reflect its commitment to supporting rigorous peer-review processes and promoting scholarly excellence. Located in Philadelphia, PA, the journal covers a wide range of topics, making it a crucial resource for those dedicated to the betterment of healthcare and medical education.

MEDICINAL RESEARCH REVIEWS, published by Wiley, is a leading journal in the fields of Drug Discovery, Molecular Medicine, and Pharmacology. With an impressive impact factor and esteemed standing in its category quartiles (Q1 in all three fields), this journal serves as a vital platform for the dissemination of cutting-edge research and reviews that drive innovation in therapeutic development and molecular health sciences. Since its inception in 1981, MEDICINAL RESEARCH REVIEWS has garnered a robust readership within the scientific community, underscored by its high rankings in Scopus – where it ranks #3 in Pharmacology and #2 in Drug Discovery, placing it within the top echelons of academic influence. Researchers, professionals, and students alike benefit from its rich content and comprehensive approaches to tackling complex medicinal challenges, making it an essential resource for those invested in advancing the frontiers of biomedical research.

Annals of Phytomedicine - An International Journal is a leading publication dedicated to the exploration and advancement of phytomedicine, broadly encompassing research on medicinal plants, their bioactive compounds, and therapeutic applications. Published by UKAAZ Publications, this journal seeks to bridge the gap between traditional and modern medicinal practices, offering a platform for researchers, professionals, and students passionate about herbal therapies and their efficacy. With an ISSN 2393-9885 and E-ISSN 2278-9839, the journal adheres to stringent peer-review protocols to ensure the publication of high-quality research. Fostering open access to knowledge in a rapidly evolving field, Annals of Phytomedicine serves as an essential resource, promoting innovative findings and comprehensive reviews that drive the global discourse on phytotherapy. By engaging with this journal, readers can stay informed about the latest advancements, contributing significantly to the scholarly community and beyond.

Phytotherapy Research, a distinguished journal published by Wiley, stands at the forefront of the pharmacological literature, delivering essential insights into the therapeutic potential of plant-based interventions. With its ISSN 0951-418X and E-ISSN 1099-1573, the journal has firmly established itself since its inception in 1987, now converging into its 2024 volume. Notably positioned in the Q1 category of Pharmacology and ranked #22 out of 313 journals in the field, it boasts a remarkable 93rd percentile rating according to Scopus. While the journal adheres to subscription-based access, it remains a crucial repository of high-quality research findings that support the understanding and advancement of herbal medicines and phytotherapeutics. This journal serves as an invaluable resource for researchers, healthcare professionals, and students alike, fostering a deeper exploration of the synergistic relationship between nature and medicine and promoting evidence-based practices in the field.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Fitoterapia is a prestigious journal published by Elsevier that specializes in the fields of drug discovery and pharmacology. Established in 1948 and featuring a comprehensive scope that encompasses all aspects of medicinal plants and their derivatives, this journal is a critical resource for researchers, professionals, and students interested in the pharmacological effects of natural products. With an impressive impact factor reflected in its Q2 ranking in both Drug Discovery and Medicine as well as a Q3 ranking in Pharmacology, Fitoterapia plays a vital role in promoting innovative research in the intersection of traditional medicine and modern pharmacological science. The journal’s commitment to quality is further highlighted by its rankings in Scopus, where it holds a notable position among peers in its field. Although Fitoterapia does not currently offer Open Access, its reputation for rigor and relevance makes it an indispensable asset for anyone engaged in herbal medicine research and development. Authors and researchers seeking to publish groundbreaking findings will find a welcoming platform to disseminate their work in this influential journal.

Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas, published by MS-EDITIONS, serves as a vital platform for the dissemination of research and insights related to medicinal and aromatic plants in Latin America and the Caribbean. With its ISSN 0717-7917, this journal operates within multiple scientific categories, achieving notable rankings, including Q3 in Complementary and Alternative Medicine and Q4 in Drug Discovery, Pharmacology, and Plant Science for 2023. The journal is committed to providing a space for high-quality research that supports the exploration of traditional and innovative uses of plant resources in health and wellness. Researchers, professionals, and students are encouraged to contribute their findings from 2008 through 2024, fostering a rich collaborative environment that advances knowledge in this essential field. Though not officially listed as open access, Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas remains a critical resource for those invested in the science of plant-based therapies and their implications in modern medicine.

Natural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.